SEC EDGAR · company profile · free

ELI LILLY & Co due diligence

Who ELI LILLY & Co (LLY) is on the public record: identity, industry classification and the most recent periodic filings, straight from SEC EDGAR.

1005 filings in EDGAR's recent index, 695 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index
CIK
0000059478
Industry (SIC)
Pharmaceutical Preparations (2834)
Incorporated
IN
Listed on
NYSE
Tickers
LLY
Fiscal year end
12-31
FilingFiledPeriodAccession
Annual report (10-K)2026-02-122025-12-310000059478-26-000013
Quarterly report (10-Q)2026-08-052026-06-300000059478-26-000081
Current report (8-K)2026-08-052026-08-050000059478-26-000077

The full due-diligence dossier on ELI LILLY & Co

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"LLY"} over x402 or MPP, $9

Sample output and API docs · all reports

LLY insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.